Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma

Background Lung adenocarcinoma (LUAD) accounts for 50% of lung cancers, with high mortality and poor prognosis. Long non-coding RNA (lncRNA) plays a vital role in the progression of tumors. Cuproptosis is a newly discovered form of cell death that is highly investigated. Therefore, in the present st...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Wang, Fangwei [verfasserIn]

Lin, Hongsheng

Su, Qisheng

Li, Chaoqian

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Schlagwörter:

Cuproptosis

lncRNAs

Signature

Prognosis

Immune

Drug sensitivity

Anmerkung:

© The Author(s) 2022

Übergeordnetes Werk:

Enthalten in: World journal of surgical oncology - London : Biomed Central, 2003, 20(2022), 1 vom: 01. Sept.

Übergeordnetes Werk:

volume:20 ; year:2022 ; number:1 ; day:01 ; month:09

Links:

Volltext

DOI / URN:

10.1186/s12957-022-02727-7

Katalog-ID:

SPR050960903

Nicht das Richtige dabei?

Schreiben Sie uns!